New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
16:38 EDTWXWuXi PharmaTech sees Q4 revenue $121M-$124M, consensus $124.92M
Sees Q4 operating margin of about 17.0% GAAP, about 20.0% non-GAAP.
News For WX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
09:18 EDTWXOn The Fly: Pre-market Movers.
UP AFTER EARNINGS: Glu Mobile (GLUU), up 28.2% after reporting first quarter results and deals with Tencent and Britney Spears... Civeo (CVEO), up 3.05... TASER (TASR), up 9.6%... Virgin America (VA), up 2.7%... Noble Corp (NE), up 1.8%... Statoil (STO), up 2.8%... Alpha Natural (ANR), up 3.6%... Exxon Mobil (XOM), up 1.4%... Phillips 66 (PSX), up 1.2%... NXP Semiconductors (NXPI), up 2.4%. ALSO HIGHER: Clicksoftware (CKSW), up 27.8% after being acquired by Francisco Partners... JetBlue (JBLU), up 1.4% after being upgraded to Outperform from Neutral at Credit Suisse... WuXi PharmaTech (WX), up 16.5% after receiving going private proposal. DOWN AFTER EARNINGS: Yelp (YELP), down 17.1%... Celgene (CELG), down 2.4%... STMicroelectronics (STM), down 11.4%... Harman International (HAR), down 9%... Potash (POT), down 2.4%... Generac (GNRC), down 7%... Nokia (NOK), down 8.7%... Baidu (BIDU), down 2.6%. ALSO LOWER: Inovio Pharmaceuticals (INO), down 18.1% after 9.5M share Spot Secondary priced at $8.00... Miller Energy (MILL), down 9% after receiving 'Wells Notice'... Scorpio Tankers (STNG), down 7.5% after 15M share Spot Secondary priced at $9.30... Advaxis (ADXS), down 6% after 2.8M share Spot Secondary priced at $19.00.
09:14 EDTWXOn The Fly: Pre-market Movers.
Subscribe for More Information
08:13 EDTWXWuXi PharmaTech to build mammalian cell culture manufacturing facility
Subscribe for More Information
07:25 EDTWXWuXi PharmaTech announces receipt of proposal
WuXi PharmaTech announced that its board has received a preliminary non-binding proposal letter, dated April 29, 2015, from a consortium led by Ge Li founder, chairman and chief executive officer of the Company, and Ally Bridge Group Capital Partners hat proposes a transaction involving the acquisition of all outstanding shares of the company not already owned by members of the Consortium for $46.00 in cash per American Depositary Share, or $5.75 in cash per ordinary share. According to the proposal letter, the Consortium will form an acquisition company for the purpose of implementing the Transaction, and the Transaction is intended to be financed with a combination of debt and equity capital. The proposal letter also states that the Chairman and ABG have agreed to work together exclusively in pursuing the Transaction. The company's board will form a special committee comprising independent directors of the company to consider the proposed transaction. The Special Committee is expected to be authorized to retain independent advisors, including a financial advisor and legal counsel, to assist it in its work.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use